PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma - Wang - 2020 - Cancer Medicine - Wiley Online Library
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes | Nature Communications
RESÚMENES DEL XLII CONGRESO DE LA SOCIEDAD ESPAÑOLA DE NEFROLOGÍA Y VII IBEROAMERICANO DE NEFROLOGÍA
Guideline Therapeutics and COVID-19: living guideline
MADS NØRGAARD – COPENHAGEN – MADS NØRGAARD - COPENHAGEN
Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany - The Lancet Regional Health – Europe
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants | Nature Communications
NAPAPIJRI Rainforest Winter - Jacket
Molecules | Free Full-Text | Strategies Tackling Viral Replication and Inflammatory Pathways as Early Pharmacological Treatment for SARS-CoV-2 Infection: Any Potential Role for Ketoprofen Lysine Salt?
Frontiers | The Mechanism of Lung and Intestinal Injury in Acute Pancreatitis: A Review
Comunicaciones orales
Guideline Therapeutics and COVID-19: living guideline
Antioxidants | Free Full-Text | The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
XXXVII Congreso SETH 2021.indd
Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement | Science
XXXVII Congreso SETH 2021.indd
Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2: Molecular Therapy - Methods & Clinical Development
